TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating Lymphocytes
Breast Care - Switzerland
doi 10.1159/000486949
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2018
Authors
Publisher
S. Karger AG